Innovus Pharmaceuticals Inc. (fka INNV)

[healthywelth]

INNV - have grown revenues from $800k in 2015 to about $5 million in 2016 and now all indications are they could be at $10 million in 2017. Along with that top line revenue growth, they are showing signs of good cost-controls and during each of the last four quarters, they have reduced their undistributed operating expenses like G&A and Sales. All this is narrowing the delta between profitability and non-profitability. If the recent trend from the past four (4) Quarters holds, we will see that we are ever so close to profitability at the NOI line. I am not hypothesizing here because we have factual information that Innovus is getting close to Profitability. Innovus' Net Income in Q3 2016 was -$4.4 million; in Q4 2016 it improved to -$3.4 million; in Q1 2017 it further improved to -$2.5 million and then in Q2 2017 it was -$1.1 million, and then in Q3 2017 it was little increase - $ 1.3 million. This trend is significant and tells me that the gradual increase in revenues and a concerted effort to control expenses is yielding positive results as show in the Income Statement. p.s.NET INCOME IN : Q3 2016 was -$4.4 million to DECREASE Q3 2017 - $1.3 million ( 73% !!!!! DECREASE ). WOW !!! not bad for growing company .